Serum direct bilirubin <  mg/dl or serum total bilirubin =< ; NOTE: the above stipulation for normal hepatic function does not apply if liver dysfunction is due to leukemia infiltration
Obtained =<  hours prior to registration: Serum direct bilirubin <  mg/dL or serum total bilirubin =< 
Direct bilirubin < . mg/dL
Direct bilirubin =< . mg/dL
Total bilirubin =< . times the institutional upper limit of normal (ULN), unless elevated secondary to lymphomatous involvement of liver or biliary system, or due to other HIV medications (e.g., indinavir, tenofovir, or atazanavir); if secondary to lymphomatous involvement, an initial upper limit of total bilirubin  mg/dL (. uM/L) should be utilized - for direct bilirubin > . mg/dL (. uM/L)
Serum direct bilirubin =<  mg/dL (unless history of Gilberts)
Obtained =<  days prior to registration: total bilirubin =< . mg/dL (if total is elevated check direct and if normal patient is eligible)
Obtained =<  days prior to registration and confirmed prior to the first dose of study drug: Total bilirubin =< . mg/dL (if total is elevated check direct and if normal patient is eligible)
Direct bilirubin ? . mg/dL or total bilirubin ? . mg/dL
Direct bilirubin ? . mg/dL ( mmol/L)
Patient may not have severe hepatic disease (direct bilirubin greater than  mg/dl OR aspartate aminotransferase [AST] greater than  IU/L), unless hepatic injury is due to LCH
Direct bilirubin < . mg/dL
Direct bilirubin > . mg/dL
Direct or conjugated bilirubin <  mg/dl
Direct bilirubin =< . mg/ ml
Direct bilirubin =< . mg/dL
Direct bilirubin =< . mg/dl
Total or direct bilirubin =< . mg/dL
Direct bilirubin <  mg/dl
Total bilirubin < . mg/dl (if total bilirubin is >= . patient is eligible if direct bilirubin is within normal limits)
Direct bilirubin =< . mg/dl
Direct bilirubin of =<  mg/dL
Direct bilirubin >= . mg/dl
Direct bilirubin < . mg/dL (. micromoles/L); Note: a total bilirubin of < . mg/dL (. micromoles/L) is acceptable to meet this requirement
Total bilirubin =< grade \r\n* Note: If total bilirubin is  to  mg/dL, but direct bilirubin is normal, then the patient will be considered eligible
Bilirubin =< grade \r\n* If bilirubin is - mg/dL, but direct bilirubin is normal then patient will be considered eligible
Total bilirubin =< . mg/dL or direct bilirubin =< . mg/dL
Direct bilirubin < . mg/dL (. micromoles/L); note: a total bilirubin of < . mg/dL (. micromoles/L) is acceptable to meet this requirement
Patients with severe hepatic disease (direct bilirubin greater than  mg/dl or aspartate aminotransferase [AST] greater than  IU/L)
Direct bilirubin =< mg/dL
Direct bilirubin =<  mg/dL
Direct bilirubin > . mg/dL
Patient with severe hepatic disease (direct bilirubin greater than  mg/dl or aspartate aminotransferase [AST] greater than  IU/L)
Patients deemed to have mild hepatic impairment should not be considered for this study; patients with a direct bilirubin level greater than . mg/dL at screening should be excluded
Total bilirubin =< . mg/dL (if total is elevated check direct and if normal patient is eligible), obtained =<  days prior to registration and confirmed prior to the first dose of study drug
The direct bilirubin must be within normal parameters
Obtained =<  days prior to registration: Total bilirubin =< . mg/dL (if total is elevated check direct and if normal patient is eligible)
Direct bilirubin < . mg/dl
Serum direct bilirubin <  mg/dL ( Omol/L) within  days prior to cycle  day 
Serum direct bilirubin <  mg/dL ( Omol/L) within  days of time of consent
Total or direct bilirubin =< . mg/dL
Total bilirubin =< . mg/dL (or direct bilirubin <  mg/dL)
Direct bilirubin less than or equal to . mg/dL
Total bilirubin =< . mg/dL obtained =<  days prior to registration (if total is elevated check direct and if normal patient is eligible)
Direct bilirubin > .mg/dL
Direct bilirubin =< . mg/dL (if total bilirubin > . mg/dL)
Direct bilirubin less than ., indirect bilirubin less than .
Bilirubin <. mg/dL or direct bilirubin <. mg/dL
Direct bilirubin =< . x the upper limit of normal (ULN); for subjects with known Gilberts disease, direct bilirubin =< . mg/dL
Direct bilirubin =< . mg/dl; Note: as many eligible patients will be pancytopenic secondary to their disease or prior treatments, hematologic abnormalities will not be used as a criteria for entry or exclusion
Direct bilirubin less than or equal to . mg/dL
Direct bilirubin equal to or less than . mg/dL
Serum direct bilirubin =< . mg/dl
Total bilirubin <   upper limit of normal, direct bilirubin < . mg/dL.
Subjects must have a serum direct bilirubin < . mg/dL unless related to Gilberts syndrome of hemolysis; if the total bilirubin =< ., direct bilirubin does not need to be drawn